Inputs: momentum, trendVelocity
Mixed signal: momentum 60/100, trend 67/100.
Prediction result · Ensemble engineUpdated 6:18 AM
EWEdwards Lifesciences Corporation stock price outlook
$92.01-2.57% since prev closeNeutral
Edwards Lifesciences Corporation (EW) is trading at $92.01, down 2.57% since the previous close and +3.3% over the past week. Price sits above its 50-day average by 4.39%, with price momentum at 60/100 and trend velocity at 67/100. Sentiment across 0 recent headlines reads mixed at 50/100. Volatility risk is contained (34/100) and the stock is 80% of the way up its 52-week range. The weighted factor score lands at 57/100 — a neutral signal. Research only, not investment advice.
Universal leanmarket
EW
Edwards Lifesciences Corporation
$92.01-2.57%
LEANNEUTRAL / wait for cleaner tape
WHY
- Edwards Lifesciences Corporation (EW) is trading at $92.01, down 2.57% since the previous close and +3.3% over the past week. Price sits above its 50-day average by 4.39%, with price momentum at 60/100 and trend velocity at 67/100. Sentiment across 0 recent headlines reads mixed at 50/100. Volatility risk is contained (34/100) and the stock is 80% of the way up its 52-week range. The weighted factor score lands at 57/100 — a neutral signal. Research only, not investment advice.
- Bull input: Calm tape (34/100) with positive momentum is the cleanest grind setup.
- Bear input: High volume on a down-move — distribution signature.
RISK
Signals are model output from public data, not personalized investment advice.
INVALIDATE
Invalidate when a clear catalyst or directional print replaces the mixed tape.
AI Signal
Neutral · Playable
live data
Full public-market mode: chart history, quote, and news inputs were available.
Chart feed
Cron market chart feed
Quote/history
Six-month public chart history loaded.
News feed
No relevant current headlines found.
Signal inputs
Technical factors and news sentiment evaluated across multiple signal inputs.
News Sentiment50/100
Price Momentum60/100
Trend Velocity67/100
Volatility Risk34/100
Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.
Why It Matters
Signal Explanation
Edwards Lifesciences Corporation (EW) is trading at $92.01, down 2.57% since the previous close and +3.3% over the past week. Price sits above its 50-day average by 4.39%, with price momentum at 60/100 and trend velocity at 67/100. Sentiment across 0 recent headlines reads mixed at 50/100. Volatility risk is contained (34/100) and the stock is 80% of the way up its 52-week range. The weighted factor score lands at 57/100 — a neutral signal. Research only, not investment advice.
Analyst Engine · Specialist model ensemble
Trees disagree — no clear lean on EW
Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.
Engine edgePlayableNeutral
Inputs: newsSentiment, dayChange
Sentiment 50/100 + price -2.6% are both mid-range.
Inputs: unusualVolume, dayChange
High volume on a down-move — distribution signature.
Inputs: volatilityRisk, momentum
Calm tape (34/100) with positive momentum is the cleanest grind setup.
Inputs: pctOfRange, trendVelocity
Near range top — needs fresh catalyst to break out.
Inputs: newsSentiment, weekChange
Sentiment 50/100 vs week change 3.3% are in agreement — no divergence edge.
Inputs: vsSma50, momentum
Price within 4.4% of the 50d SMA — no clear structural read.
Inputs: momentum, trendVelocity
Oscillator at 64 — healthy uptrend region.
Inputs: momentum, dayChange, vsSma50
Momentum 60/100 is not strong enough to confirm a breakout.
Inputs: newsSentiment, weekChange
News 50/100 and weekly change 3.3% do not create a clean follow-through read.
Inputs: unusualVolume, trendVelocity
Volume 71/100 does not show a dry-up signal.
Inputs: volatilityRisk, pctOfRange, momentum
Volatility 34/100 does not give a clean compression read.
Inputs: pctOfRange, dayChange, weekChange
Range position 80% is too middle-of-the-road to matter.
Inputs: newsSentiment, momentum, weekChange
Sentiment 50/100 and momentum 60/100 are not aligned enough for a clean read.
Inputs: vsSma50, momentum, trendVelocity
Price is above the 50d SMA and both momentum and trend velocity are holding up.
Inputs: momentum, trendVelocity, weekChange
Oscillator at 64 does not show a rebound edge.
Why the ensemble agrees
- Mixed signal: momentum 60/100, trend 67/100.
- Near range top — needs fresh catalyst to break out.
- Sentiment 50/100 + price -2.6% are both mid-range.
Counter-trees
- High volume on a down-move — distribution signature.
- Calm tape (34/100) with positive momentum is the cleanest grind setup.
Bull Case
- Calm tape (34/100) with positive momentum is the cleanest grind setup.
- Oscillator at 64 — healthy uptrend region.
- Price is above the 50d SMA and both momentum and trend velocity are holding up.
Bear Case
- High volume on a down-move — distribution signature.
Latest Market Headlines
Headline titles only, from the publisher named on each card. Each links to the original story.
No current headlines passed the relevance filter. The watch panel above still shows the catalysts and risk factors being tracked.
Key stats
- Sector
- Health Care
- Industry
- Industrial Specialties
- Market cap
- $53.03B
- 52-week range
- $96.29/$74.66
- Volume
- 6,044,702
- Avg volume
- 2,718,227
- Analyst 1-yr target
- $102.00
- Exchange
- NYSE
Source: Nasdaq public quote data. Research only.
Earnings Intelligence
Next
Nov 4, 2026
Estimate
$0.73
Actual
$0.78
- • Last report Jul 23, 2026 (Jun 2026): EPS $0.78 vs $0.73 expected, +6.85% surprise.
- • Beat estimates in 3 of the last 4 quarters.
- • Next report expected Nov 4, 2026, consensus EPS $0.73 (Zacks estimate via Nasdaq; the company may confirm a different date).
Risk Warnings
- • Signals are model output from public data, not personalized investment advice.
- • Markets can move against any signal regardless of the score.
- • Confirm liquidity, spreads, and your own thesis before acting.
EW questions
What is the MarketPicks AI signal for Edwards Lifesciences Corporation stock (EW)?
As of Nov 2, 1:18 AM ET, the ensemble reads neutral on EW — no consensus — 12 of 16 bots holding, with 3 bull, 1 bear and 12 hold votes from 16 specialist bots. Research only, not investment advice.
What is the latest EW price on MarketPicks?
EW was $92.01 on the latest quote (Nov 2, 1:18 AM ET), -2.57% since the previous close. Quotes can be delayed.
What do the momentum and trend scores for EW mean?
Scores run from 0 to 100, with 50 neutral. EW shows momentum 60/100, trend velocity 67/100 and volatility risk 34/100, with news sentiment at 50/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.